Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Juan, PR
NPI
1700223021
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
San Jorge Building 270
San Juan, PR, 00912
Phone (787) 727-1000
Medicare paid, 2024
$7,360
112 services
Medicare patients, 2024
51
Average age 74
Drug cost, 2024
$2.7M
9,404 prescriptions
Company payments, 2023
$20.06
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen Torres Gonzalez was code 99213 (office e&m - established), 94 times for 43 patients. In total Karen Torres Gonzalez billed 112 services in 3 codes, and Medicare paid $7,360.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 94 | 43 | $57.69 | $5,423 |
| 99204 Office E&M - New | Office | 13 | 13 | $120.37 | $1,565 |
By year: 2022 $7,386 for 112 services; 2023 $6,795 for 105 services; 2024 $7,360 for 112 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karen Torres Gonzalez prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,404 prescriptions and refills. In total Karen Torres Gonzalez wrote 9,404 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,404 | 2,114 | 266 | $100K |
| Glimepiride Generic | 1,010 | 1,429 | 193 | $12K |
| Rosuvastatin Calcium Generic | 671 | 1,089 | 171 | $7,357 |
| Ozempic Semaglutide | 520 | 553 | 72 | $537K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 507 | 561 | 75 | $343K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 375 | 414 | 66 | $254K |
| Farxiga Dapagliflozin Propanediol | 340 | 384 | 57 | $222K |
| Atorvastatin Calcium Generic | 324 | 593 | 95 | $3,171 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 303 | 350 | 46 | $208K |
| Metformin Hcl Generic | 217 | 359 | 54 | $1,672 |
| Mounjaro Tirzepatide | 194 | 199 | 27 | $213K |
| Omega-3 Acid Ethyl Esters Generic | 194 | 283 | 49 | $11K |
| Jardiance Empagliflozin | 184 | 219 | 39 | $134K |
| Pioglitazone Hcl Generic | 183 | 259 | 40 | $2,482 |
| Metformin Hcl Er Metformin Hcl | 172 | 284 | 50 | $1,692 |
Brand drugs: 5,114 claims; generic drugs: 4,115 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Karen Torres Gonzalez $20.06 ($20.06 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $20.06.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $20.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.